Selected research
Industry Research
Drug and Medical Device Testing Services Industry Research Report 2026
Market perspective
The global Drug and Medical Device Testing Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Drug and Medical Device Testing Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Drug and Medical Device Testing Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Drug and Medical Device Testing Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Drug and Medical Device Testing Services include SGS, Intertek, Eurofins, Bureau Veritas, TÜV SÜD, DEKRA, UL, TÜV Rheinland and NAMSA, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Drug and Medical Device Testing Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Drug and Medical Device Testing Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Drug and Medical Device Testing Services Market by Company
SGS
Intertek
Eurofins
Bureau Veritas
TÜV SÜD
DEKRA
UL
TÜV Rheinland
NAMSA
BSI Group
Jiangsu Bioperfectus Technologies Co.,Ltd.
SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co.
Henan Zhongmei Technical Inspection Service Co.
Wuxi New Drug Development Co., Ltd. Shanghai
Drug and Medical Device Testing Services Segment by Type
Drug Testing
Medical Device Testing
Drug and Medical Device Testing Services Segment by Application
Pharmaceutical
Medical Instruments
Drug R&D and Clinical Trials
Others
Drug and Medical Device Testing Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug and Medical Device Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug and Medical Device Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug and Medical Device Testing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Drug and Medical Device Testing Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Drug Testing
- Medical Device Testing
Applications
- Pharmaceutical
- Medical Instruments
- Drug R&D and Clinical Trials
- Others
Companies covered
- SGS
- Intertek
- Eurofins
- Bureau Veritas
- TÜV SÜD
- DEKRA
- UL
- TÜV Rheinland
- NAMSA
- BSI Group
- Jiangsu Bioperfectus Technologies Co.,Ltd.
- SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co.
- Henan Zhongmei Technical Inspection Service Co.
- Wuxi New Drug Development Co., Ltd. Shanghai
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Drug and Medical Device Testing Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Drug Testing
- 2.2.3 Medical Device Testing
- 2.3 Drug and Medical Device Testing Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical
- 2.3.3 Medical Instruments
- 2.3.4 Drug R&D and Clinical Trials
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Drug and Medical Device Testing Services Breakdown Data by Type
- 3.1 Global Drug and Medical Device Testing Services Historic Market Size by Type (2021-2026)
- 3.2 Global Drug and Medical Device Testing Services Forecasted Market Size by Type (2027-2032)
4 Drug and Medical Device Testing Services Breakdown Data by Application
- 4.1 Global Drug and Medical Device Testing Services Historic Market Size by Application (2021-2026)
- 4.2 Global Drug and Medical Device Testing Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Drug and Medical Device Testing Services Market Perspective (2021-2032)
- 5.2 Global Drug and Medical Device Testing Services Growth Trends by Region
- 5.2.1 Global Drug and Medical Device Testing Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Drug and Medical Device Testing Services Historic Market Size by Region (2021-2026)
- 5.2.3 Drug and Medical Device Testing Services Forecasted Market Size by Region (2027-2032)
- 5.3 Drug and Medical Device Testing Services Market Dynamics
- 5.3.1 Drug and Medical Device Testing Services Industry Trends
- 5.3.2 Drug and Medical Device Testing Services Market Drivers
- 5.3.3 Drug and Medical Device Testing Services Market Challenges
- 5.3.4 Drug and Medical Device Testing Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Drug and Medical Device Testing Services Players by Revenue
- 6.1.1 Global Top Drug and Medical Device Testing Services Players by Revenue (2021-2026)
- 6.1.2 Global Drug and Medical Device Testing Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Drug and Medical Device Testing Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Drug and Medical Device Testing Services Head Office and Area Served
- 6.4 Global Drug and Medical Device Testing Services Players, Product Type & Application
- 6.5 Global Drug and Medical Device Testing Services Manufacturers Established Date
- 6.6 Global Drug and Medical Device Testing Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Drug and Medical Device Testing Services Market Size (2021-2032)
- 7.2 North America Drug and Medical Device Testing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Drug and Medical Device Testing Services Market Size by Country (2021-2026)
- 7.4 North America Drug and Medical Device Testing Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Drug and Medical Device Testing Services Market Size (2021-2032)
- 8.2 Europe Drug and Medical Device Testing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Drug and Medical Device Testing Services Market Size by Country (2021-2026)
- 8.4 Europe Drug and Medical Device Testing Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Drug and Medical Device Testing Services Market Size (2021-2032)
- 9.2 Asia-Pacific Drug and Medical Device Testing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Drug and Medical Device Testing Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Drug and Medical Device Testing Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Drug and Medical Device Testing Services Market Size (2021-2032)
- 10.2 South America Drug and Medical Device Testing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Drug and Medical Device Testing Services Market Size by Country (2021-2026)
- 10.4 South America Drug and Medical Device Testing Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Drug and Medical Device Testing Services Market Size (2021-2032)
- 11.2 Middle East & Africa Drug and Medical Device Testing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Drug and Medical Device Testing Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Drug and Medical Device Testing Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 SGS
- 12.1.1 SGS Company Information
- 12.1.2 SGS Business Overview
- 12.1.3 SGS Revenue in Drug and Medical Device Testing Services Business (2021-2026)
- 12.1.4 SGS Drug and Medical Device Testing Services Product Portfolio
- 12.1.5 SGS Recent Developments
- 12.2 Intertek
- 12.2.1 Intertek Company Information
- 12.2.2 Intertek Business Overview
- 12.2.3 Intertek Revenue in Drug and Medical Device Testing Services Business (2021-2026)
- 12.2.4 Intertek Drug and Medical Device Testing Services Product Portfolio
- 12.2.5 Intertek Recent Developments
- 12.3 Eurofins
- 12.3.1 Eurofins Company Information
- 12.3.2 Eurofins Business Overview
- 12.3.3 Eurofins Revenue in Drug and Medical Device Testing Services Business (2021-2026)
- 12.3.4 Eurofins Drug and Medical Device Testing Services Product Portfolio
- 12.3.5 Eurofins Recent Developments
- 12.4 Bureau Veritas
- 12.4.1 Bureau Veritas Company Information
- 12.4.2 Bureau Veritas Business Overview
- 12.4.3 Bureau Veritas Revenue in Drug and Medical Device Testing Services Business (2021-2026)
- 12.4.4 Bureau Veritas Drug and Medical Device Testing Services Product Portfolio
- 12.4.5 Bureau Veritas Recent Developments
- 12.5 TÜV SÜD
- 12.5.1 TÜV SÜD Company Information
- 12.5.2 TÜV SÜD Business Overview
- 12.5.3 TÜV SÜD Revenue in Drug and Medical Device Testing Services Business (2021-2026)
- 12.5.4 TÜV SÜD Drug and Medical Device Testing Services Product Portfolio
- 12.5.5 TÜV SÜD Recent Developments
- 12.6 DEKRA
- 12.6.1 DEKRA Company Information
- 12.6.2 DEKRA Business Overview
- 12.6.3 DEKRA Revenue in Drug and Medical Device Testing Services Business (2021-2026)
- 12.6.4 DEKRA Drug and Medical Device Testing Services Product Portfolio
- 12.6.5 DEKRA Recent Developments
- 12.7 UL
- 12.7.1 UL Company Information
- 12.7.2 UL Business Overview
- 12.7.3 UL Revenue in Drug and Medical Device Testing Services Business (2021-2026)
- 12.7.4 UL Drug and Medical Device Testing Services Product Portfolio
- 12.7.5 UL Recent Developments
- 12.8 TÜV Rheinland
- 12.8.1 TÜV Rheinland Company Information
- 12.8.2 TÜV Rheinland Business Overview
- 12.8.3 TÜV Rheinland Revenue in Drug and Medical Device Testing Services Business (2021-2026)
- 12.8.4 TÜV Rheinland Drug and Medical Device Testing Services Product Portfolio
- 12.8.5 TÜV Rheinland Recent Developments
- 12.9 NAMSA
- 12.9.1 NAMSA Company Information
- 12.9.2 NAMSA Business Overview
- 12.9.3 NAMSA Revenue in Drug and Medical Device Testing Services Business (2021-2026)
- 12.9.4 NAMSA Drug and Medical Device Testing Services Product Portfolio
- 12.9.5 NAMSA Recent Developments
- 12.10 BSI Group
- 12.10.1 BSI Group Company Information
- 12.10.2 BSI Group Business Overview
- 12.10.3 BSI Group Revenue in Drug and Medical Device Testing Services Business (2021-2026)
- 12.10.4 BSI Group Drug and Medical Device Testing Services Product Portfolio
- 12.10.5 BSI Group Recent Developments
- 12.11 Jiangsu Bioperfectus Technologies Co.,Ltd.
- 12.11.1 Jiangsu Bioperfectus Technologies Co.,Ltd. Company Information
- 12.11.2 Jiangsu Bioperfectus Technologies Co.,Ltd. Business Overview
- 12.11.3 Jiangsu Bioperfectus Technologies Co.,Ltd. Revenue in Drug and Medical Device Testing Services Business (2021-2026)
- 12.11.4 Jiangsu Bioperfectus Technologies Co.,Ltd. Drug and Medical Device Testing Services Product Portfolio
- 12.11.5 Jiangsu Bioperfectus Technologies Co.,Ltd. Recent Developments
- 12.12 SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co.
- 12.12.1 SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co. Company Information
- 12.12.2 SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co. Business Overview
- 12.12.3 SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co. Revenue in Drug and Medical Device Testing Services Business (2021-2026)
- 12.12.4 SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co. Drug and Medical Device Testing Services Product Portfolio
- 12.12.5 SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co. Recent Developments
- 12.13 Henan Zhongmei Technical Inspection Service Co.
- 12.13.1 Henan Zhongmei Technical Inspection Service Co. Company Information
- 12.13.2 Henan Zhongmei Technical Inspection Service Co. Business Overview
- 12.13.3 Henan Zhongmei Technical Inspection Service Co. Revenue in Drug and Medical Device Testing Services Business (2021-2026)
- 12.13.4 Henan Zhongmei Technical Inspection Service Co. Drug and Medical Device Testing Services Product Portfolio
- 12.13.5 Henan Zhongmei Technical Inspection Service Co. Recent Developments
- 12.14 Wuxi New Drug Development Co., Ltd. Shanghai
- 12.14.1 Wuxi New Drug Development Co., Ltd. Shanghai Company Information
- 12.14.2 Wuxi New Drug Development Co., Ltd. Shanghai Business Overview
- 12.14.3 Wuxi New Drug Development Co., Ltd. Shanghai Revenue in Drug and Medical Device Testing Services Business (2021-2026)
- 12.14.4 Wuxi New Drug Development Co., Ltd. Shanghai Drug and Medical Device Testing Services Product Portfolio
- 12.14.5 Wuxi New Drug Development Co., Ltd. Shanghai Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst